Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation
- 15 February 2017
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 34 (5) , 1115-1124
Abstract
Amphotericin B (AmB) and 5-fluorocytosine (5-FC) exhibit additive to synergistic activity against systemic mycoses. Incompatibility of prescribed formulations precludes concomitant IV administration, a route with distinct advantages. Previously, we used PEG-DSPE micelles to produce a reformulation of Fungizone (AmB-SD), AmB solubilized by sodium deoxycholate, called mAmB-90. Herein, we describe a second reformulation that facilitates co-delivery of mAmB-90 and 5-FC, and evaluate the effect of PEG-DSPE micelles on the combination’s activity against Candida albicans.Keywords
Funding Information
- National Institutes of Health (R01 AI-43346)
- National Science Foundation
This publication has 45 references indexed in Scilit:
- Amphotericin primarily kills yeast by simply binding ergosterolProceedings of the National Academy of Sciences, 2012
- COMMUNICATION: Pharmacokinetics and Nephrotoxicity of Amphotericin B-Incorporated Poly(Ethylene Glycol)-Block-Poly(N-Hexyl Stearate l-aspartamide) MicellesJournal of Pharmaceutical Sciences, 2011
- Antifungal Therapeutic Drug Monitoring: Established and Emerging IndicationsAntimicrobial Agents and Chemotherapy, 2009
- Flucytosine therapeutic monitoring: 15 years experience from the UKJournal of Antimicrobial Chemotherapy, 2007
- Oral versus Intravenous Flucytosine in Patients with Human Immunodeficiency Virus-Associated Cryptococcal MeningitisAntimicrobial Agents and Chemotherapy, 2007
- Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest MethodsAntimicrobial Agents and Chemotherapy, 2005
- Mortality and Costs of Acute Renal Failure Associated with Amphotericin B TherapyClinical Infectious Diseases, 2001
- Pharmacodynamics of Amphotericin B in a Neutropenic-Mouse Disseminated-Candidiasis ModelAntimicrobial Agents and Chemotherapy, 2001
- Turbidometric characterization of the postantifungal effect: comparative studies with amphotericin B, 5‐fluorocytosine and miconazole on Candida albicansMycoses, 1991
- Synergism of Amphotericin B and 5-Fluorocytosine for Candida SpeciesThe Journal of Infectious Diseases, 1975